Cargando…
Abnormalities in Glucose Metabolism, Appetite-Related Peptide Release, and Pro-inflammatory Cytokines Play a Central Role in Appetite Disorders in Peritoneal Dialysis
Background: Appetite disorders are frequent and scantly studied in peritoneal dialysis (PD) patients and are associated with malnutrition and cardiovascular complications. Objective: We investigated the relationship between uremic insulin resistance, pro-inflammatory cytokines, and appetite-related...
Autores principales: | Avila-Carrasco, Lorena, Pavone, Mario A., González, Elena, Aguilera-Baca, Álvaro, Selgas, Rafael, del Peso, Gloria, Cigarran, Secundino, López-Cabrera, Manuel, Aguilera, Abelardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6547940/ https://www.ncbi.nlm.nih.gov/pubmed/31191339 http://dx.doi.org/10.3389/fphys.2019.00630 |
Ejemplares similares
-
Tamoxifen Ameliorates Peritoneal Membrane Damage by Blocking Mesothelial to Mesenchymal Transition in Peritoneal Dialysis
por: Loureiro, Jesús, et al.
Publicado: (2013) -
An appetite for understanding appetite
por: Gasque, Gabriel
Publicado: (2017) -
Nebivolol, a β1-adrenergic blocker, protects from peritoneal membrane damage induced during peritoneal dialysis
por: Liappas, Georgios, et al.
Publicado: (2016) -
Correction: Nebivolol, a β(1)-adrenergic blocker, protects from peritoneal membrane damage induced during peritoneal dialysis
por: Liappas, Georgios, et al.
Publicado: (2017) -
Appetite
Publicado: (1855)